Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cognitive Function in Older Women With Stage I, Stage II, or Stage III Breast Cancer Receiving Hormone Therapy
Sponsor: City of Hope Medical Center
Summary
RATIONALE: Gathering information about cognitive function over time in postmenopausal women with breast cancer may help doctors learn about the long-term effects of aromatase inhibitor therapy and plan the best treatment. PURPOSE: This clinical trial is studying cognitive function in older postmenopausal women with stage I, stage II, or stage III breast cancer receiving hormone therapy and in healthy volunteers.
Official title: The Effect of Aromatase Inhibition on the Cognitive Function of Older Patients With Breast Cancer
Key Details
Gender
FEMALE
Age Range
65 Years - Any
Study Type
OBSERVATIONAL
Enrollment
72
Start Date
2007-12-05
Completion Date
2011-01-01
Last Updated
2026-10-19
Healthy Volunteers
Yes
Conditions
Interventions
anastrozole
As determined by the subject's physician
letrozole
As determined by the subject's physician
questionnaire administration
For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.
cognitive assessment
For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.
psychosocial assessment and care
For cancer patients prior to starting medication and 6 months after starting medication. For healthy controls, one time administration.
Locations (1)
City of Hope Comprehensive Cancer Center
Duarte, California, United States